rs13324
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003873.7(NRP1):c.*1354C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.365 in 152,248 control chromosomes in the GnomAD database, including 11,214 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.37 ( 11208 hom., cov: 32)
Exomes 𝑓: 0.23 ( 6 hom. )
Consequence
NRP1
NM_003873.7 3_prime_UTR
NM_003873.7 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.458
Genes affected
NRP1 (HGNC:8004): (neuropilin 1) This gene encodes one of two neuropilins, which contain specific protein domains which allow them to participate in several different types of signaling pathways that control cell migration. Neuropilins contain a large N-terminal extracellular domain, made up of complement-binding, coagulation factor V/VIII, and meprin domains. These proteins also contains a short membrane-spanning domain and a small cytoplasmic domain. Neuropilins bind many ligands and various types of co-receptors; they affect cell survival, migration, and attraction. Some of the ligands and co-receptors bound by neuropilins are vascular endothelial growth factor (VEGF) and semaphorin family members. This protein has also been determined to act as a co-receptor for SARS-CoV-2 (which causes COVID-19) to infect host cells. [provided by RefSeq, Nov 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.594 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NRP1 | NM_003873.7 | c.*1354C>T | 3_prime_UTR_variant | 17/17 | ENST00000374867.7 | NP_003864.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NRP1 | ENST00000374867.7 | c.*1354C>T | 3_prime_UTR_variant | 17/17 | 1 | NM_003873.7 | ENSP00000364001 | P3 | ||
NRP1 | ENST00000374875.5 | c.*1354C>T | 3_prime_UTR_variant | 16/16 | 1 | ENSP00000364009 | ||||
NRP1 | ENST00000395995.5 | c.*1354C>T | 3_prime_UTR_variant | 16/16 | 1 | ENSP00000379317 | A2 | |||
NRP1 | ENST00000265371.8 | c.*1354C>T | 3_prime_UTR_variant | 18/18 | 5 | ENSP00000265371 | P3 |
Frequencies
GnomAD3 genomes AF: 0.365 AC: 55494AN: 151848Hom.: 11197 Cov.: 32
GnomAD3 genomes
AF:
AC:
55494
AN:
151848
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.232 AC: 65AN: 280Hom.: 6 Cov.: 0 AF XY: 0.247 AC XY: 42AN XY: 170
GnomAD4 exome
AF:
AC:
65
AN:
280
Hom.:
Cov.:
0
AF XY:
AC XY:
42
AN XY:
170
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.365 AC: 55537AN: 151968Hom.: 11208 Cov.: 32 AF XY: 0.362 AC XY: 26895AN XY: 74274
GnomAD4 genome
AF:
AC:
55537
AN:
151968
Hom.:
Cov.:
32
AF XY:
AC XY:
26895
AN XY:
74274
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1661
AN:
3472
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at